TCTMD: Bleeds on anticoagulants for atrial fibrillation can unveil occult cancers
UC cardiologist weighs in on research findings out of Spain
TCTMD, a publication of the Cardiovascular Research Foundation, covered the results of an observational study of 9,000 elderly patients on oral anticoagulants in Spain that suggests bleeding thought related to antithrombotic therapy may be an early warning sign for as-yet-undetected cancer.
The researcher out of Spain, Sergio Raposeiras Rubin, MD, PhD, says oral anticoagulants can be considered a ‘bleeding stress test’ and could detect occult cancer and improve the chance of early detection. His findings were published in the Journal of the American Heart Association
Richard Becker, MD, director of the University of Cincinnati Heart, Lung and Vascular Institute, also weighed in on the research.
“Bleeding, while a known side effect of oral anticoagulants must never be taken for granted,” Becker told TCTMD.
These results “serve as an important reminder to patients and clinicians alike that bleeding while on an oral anticoagulant may be an important signal or ‘red flag’ for a serious underlying condition, like cancer,” he commented in an email to TCTMD. “Early identification and treatment may have a major effect on outcome.”
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up on all UC's COVID-19 stories, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
Community disadvantage linked to increased motor symptom...
July 24, 2025
Neurology Live highlighted research led by the University of Cincinnati's Emily Hill that found community disadvantage was associated with worse motor symptom severity and motor disability in patients with Parkison disease (PD) and atypical parkinsonisms.
Managing outpatient challenges for hypertensive intracerebral...
July 23, 2025
The University of Cincinnati Gardner Neuroscience Institute's Yasmin Aziz, MD, was featured in a MedCentral article discussing the challenges of managing hypertensive intracerebral hemorrhage in outpatient settings.
Donors drive record-breaking support for UC and UC Health
July 22, 2025
Generous donors have propelled the University of Cincinnati and UC Health to a historic fundraising year, contributing an unprecedented $228,479,079 in support.